mdlinx mdlinx

Family Medicine - Pain Management News & Articles

MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the ‘headlines’ covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, and many more.

Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Family Medicine!

Articles

Latest (4) Full Text Articles (157) Focus on Substance Abuse
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

601 Predictors of Improvement in Patients With Acute and Chronic Low Back Pain Undergoing Chiropractic Treatment Journal of Manipulative and Physiological Therapeutics, October 19, 2012

602 Effect of milnacipran on body weight in patients with fibromyalgia Full Text International Journal of General Medicine, October 19, 2012    Clinical Article

603 Fluoroscopic caudal epidural injections in managing chronic axial low back pain without disc herniation, radiculitis, or facet joint pain Full Text Journal of Pain Research, October 19, 2012    Clinical Article

604 Risk Factors for the Onset of Nonspecific Low Back Pain in Office Workers: A Systematic Review of Prospective Cohort Studies Journal of Manipulative and Physiological Therapeutics, October 19, 2012    Evidence Based Medicine

605 Differential Diagnosis and Management of Ankylosing Spondylitis Masked as Adhesive Capsulitis: A Residents Case Problem Journal of Orthopaedic & Sports Physical Therapy, October 19, 2012

606 Comparative Effectiveness of Traditional Chinese Medicine and Psychosocial Care in the Treatment of Temporomandibular Disorders-Associated Chronic Facial Pain The Journal of Pain, October 18, 2012    Clinical Article

607 Success, failure and putative mechanisms in hypothalamic stimulation for drug-resistant chronic cluster headache Pain, October 18, 2012

608 No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients European Journal of Pain, October 18, 2012    Clinical Article

609 Relationship Status and Quality Moderate Daily Pain-Related Changes in Physical Disability, Affect, and Cognitions in Women with Chronic Pain Pain, October 18, 2012

610 HIZs relation to axial load and low back pain: investigated with axial loaded MRI and pressure controlled discography European Spine Journal, October 18, 2012    Clinical Article

611 Factor Structure and Psychometric Properties of the Resilience Scale in a Spanish Chronic Musculoskeletal Pain Sample The Journal of Pain, October 18, 2012

612 The relationship between pain, disability, quality of life and cognitive-behavioural factors in chronic back pain Disability & Rehabilitation, October 17, 2012

613 Guidelines for Neuropathic Pain Management in Patients with Cancer: A European Survey and Comparison Pain Practice, October 17, 2012

614 Stress and sleep duration predict headache severity in chronic headache sufferers Pain, October 17, 2012

615 A Web-Based Intervention to Improve and Prevent Low Back Pain Among Office Workers: A Randomized Controlled Trial Journal of Orthopaedic & Sports Physical Therapy, October 17, 2012

616 The hidden effects of blinded, placebo-controlled randomized trials: An experimental investigation Pain, October 17, 2012

617 Consumers experiences of back pain in rural Western Australia: access to information and services, and self-management behaviours Full Text BMC Health Services Research, October 17, 2012

618 Effects of long-term home-based exercise on health-related quality of life in patients with chronic neck pain: A randomized study with a 1-year follow-up Disability & Rehabilitation, October 16, 2012    Clinical Article

619 Patient Age is Related to the Types of Physical Therapy Interventions Provided for Chronic Low Back Pain – An Observational Study Journal of Orthopaedic & Sports Physical Therapy, October 16, 2012    Clinical Article

620 Therapist knowledge, adherence and use of low back pain guidelines to inform clinical decisions Manual Therapy , October 16, 2012

50 available pages First Previous 31 32 33 34 35 36 37 38 39 40 Next Last

Clinical Pearls in Family Medicine

Highlights in Family Medicine

Vitamin D supplementation decreases systemic inflammation in T2DM

In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.

Read the article summary

Mediterranean diet associated with decreased diabetes, cardiovascular events, and all-cause mortality

Researchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.

Read the article summary

Natalizumab superior to IFN-? 1a in MS patients

Based on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Family Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close